Retinoids induce cytochrome P450 3A4 through RXR/VDR-mediated pathway

被引:68
作者
Wang, Kun [1 ]
Chen, Shiyonq [1 ]
Xie, Wen [2 ,3 ]
Wan, Yu-Jui Yvonne [1 ]
机构
[1] Univ Kansas, Med Ctr, Dept Pharmacol Toxicol & Therapeut, Kansas City, KS 66160 USA
[2] Univ Pittsburgh, Ctr Pharmacogenet, Pittsburgh, PA 15261 USA
[3] Univ Pittsburgh, Dept Pharmaceut Sci, Pittsburgh, PA 15261 USA
关键词
VDR; RXR; retinoid; CYP3A4;
D O I
10.1016/j.bcp.2008.02.030
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
A panel of retinoids and carotenoids was screened as potential inducers of CYP3A4 through the RXR/VDR-mediated signaling pathway. Transient transfection. assays revealed that 3 out of 12 retinoids screened transactivated RXR alpha/VDR and induced CYP3A4 reporter activity. These three retinoids are the active metabolites of retinoids, 9-cis-retinal, 9-cis-retinoic acid (9-cis-RA), and all-trans-retinoic acid (all-trans-RA). 9-cis-RA and all-trans-RA preferentially transactivated the RXR/VDR heterodimers and RXR homodimers. Retinoids and VDR agonist 1 alpha, 25-dihydroxyvitamin D-3, but not PXR or CAR activator, could induce Cyp3a11 mRNA level in hepatocytes derived from PXR/CAR-double null mouse. Moreover, retinoids induced CYP3A4 enzyme activity in HepG2 human hepatoma and Caco-2 human colorectal adenocarcinoma cells. A direct role of retinoid-mediated CYP3A4 induction through RXRa/VDR was proved by the results that 9-cis-retinal, 9-cis-RA, and all-trans-RA recruited RXR alpha and VDR to CYP3A4 regulatory region pER6 (proximal everted repeat with a 6-nucleotide spacer) and dXREM (distal xenobiotic-responsive enhancer module). Thus, using various approaches, we have unequivocally demonstrated that retinoids transactivate RXR/VDR heterodimers and RXR homodimers and induce CYP3A expression at mRNA as well as enzyme activity levels in both liver and intestinal cells. It is possible that retinoids might alter endobiotic metabolism through CYP3A4 induction in vivo. (C) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:2204 / 2213
页数:10
相关论文
共 36 条
[21]   Identification of human cytochrome P450 isoforms that contribute to all-trans-Retinoic Acid 4-hydroxylation [J].
McSorley, LC ;
Daly, AK .
BIOCHEMICAL PHARMACOLOGY, 2000, 60 (04) :517-526
[22]   Clinical importance of the cytochromes P450 [J].
Nebert, DW ;
Russell, DW .
LANCET, 2002, 360 (9340) :1155-1162
[23]   Retinoic acid metabolism blocking agents (RAMBAs) for treatment of cancer and dermatological diseases [J].
Njar, Vincent C. O. ;
Gediya, Lalji ;
Purushottamachar, Puranik ;
Chopra, Pankaj ;
Vasaitis, Tadas Sean ;
Khandelwal, Aakanksha ;
Mehta, Jhalak ;
Huynh, Carlic ;
Belosay, Aashvini ;
Patel, Jyoti .
BIOORGANIC & MEDICINAL CHEMISTRY, 2006, 14 (13) :4323-4340
[24]   Dual effect of dexamethasone on CYP3A4 gene expression in human hepatocytes -: Sequential role of glucocorticoid receptor and pregnane X receptor [J].
Pascussi, JM ;
Drocourt, L ;
Gerbal-Chaloin, S ;
Fabre, JM ;
Maurel, P ;
Vilarem, MJ .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (24) :6346-6357
[25]  
Schmiedlin-Ren P, 2001, DRUG METAB DISPOS, V29, P1446
[26]   The phantom ligand effect: Allosteric control of transcription by the retinoid X receptor [J].
Schulman, IG ;
Li, C ;
Schwabe, JWR ;
Evans, RM .
GENES & DEVELOPMENT, 1997, 11 (03) :299-308
[27]  
Seglen P O, 1976, Methods Cell Biol, V13, P29, DOI 10.1016/S0091-679X(08)61797-5
[28]   Vitamin D receptor ontogenesis in rat liver [J].
Segura, C ;
Alonso, M ;
Fraga, C ;
García-Caballero, T ;
Diéguez, C ;
Pérez-Fernández, R .
HISTOCHEMISTRY AND CELL BIOLOGY, 1999, 112 (02) :163-167
[29]   Distinct retinoid X receptor activation function-2 residues mediate transactivation in homodimeric and vitamin D receptor heterodimeric contexts [J].
Thompson, PD ;
Remus, LS ;
Hsieh, JC ;
Jurutka, PW ;
Whitfield, GK ;
Galligan, MA ;
Dominguez, CE ;
Haussler, CA ;
Haussler, MR .
JOURNAL OF MOLECULAR ENDOCRINOLOGY, 2001, 27 (02) :211-227
[30]   Transcriptional control of intestinal cytochrome P-4503A by 1α,25-dihydroxy vitamin D3 [J].
Thummel, KE ;
Brimer, C ;
Yasuda, K ;
Thottassery, J ;
Senn, T ;
Lin, Y ;
Ishizuka, H ;
Kharasch, E ;
Schuetz, J ;
Schuetz, E .
MOLECULAR PHARMACOLOGY, 2001, 60 (06) :1399-1406